Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101

Part of paid clinical trials in San Francisco, California.

Sponsor
Excision BioTherapeutics
Study ID
NCT05143307
Phase
PHASE1
Status
Enrolling By Invitation

Conditions

  • HIV-1-infection

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • EBT-101 — BIOLOGICAL
    Long term follow up of participants who received EBT-101

Study Details

Participants who receive EBT-101 in a parent protocol will be eligible to participate in this long-term follow-up (LTFU) study (EBT-101-002).

Key Dates

Start date
Jul 11, 2023
Status verified
May 2024
Primary completion
Jan 31, 2037
Completion
Apr 30, 2037

Study Design

Enrollment
9 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Long Term Follow Up
    Participants who received EBT-101 in a parent study will undergo long term follow up

Primary Outcome Measure

Long-term safety of EBT-101 [ Time Frame: 15 years ]

Locations (3)

FacilityCityStateZIPSite coordinators
Quest Clinical ResearchSan FranciscoCalifornia94115-
Washington UniversitySt LouisMissouri63110-
Cooper HealthCamdenNew Jersey08103-

Find similar trials in San Francisco, CA

By research site
Quest Clinical Research· San Francisco, CAWashington University· St Louis, MOCooper Health· Camden, NJ

Related Studies